To issue a solicitation for "Mouse Models for Down

SOL #: 75N94026R00006Solicitation

Overview

Buyer

Health And Human Services
National Institutes Of Health
NATIONAL INSTITUTES OF HEALTH NICHD
BETHESDA, MD, 20817, United States

Place of Performance

Place of performance not available

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

Health R&D Services; Health Care Services; Applied Research (AN12)

Set Aside

No set aside specified

Timeline

1
Posted
Mar 9, 2026
2
Last Updated
Apr 24, 2026
3
Submission Deadline
May 28, 2026, 8:30 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has issued a solicitation for a "Repository of Mouse Models for Down Syndrome." This unrestricted opportunity seeks a contractor to produce, maintain, and distribute aneuploid mice for Down syndrome research. Proposals are due May 28, 2026.

Purpose & Scope

The primary purpose is to establish and maintain a repository of mouse models for human trisomy for chromosome 21 (Down syndrome). The selected contractor will be responsible for:

  • Producing, maintaining, and distributing specific mouse strains, including Ts65Dn (at least 30 breeding pairs), Dup(16)Yey, TcMAC21, and Ts66Yah.
  • Ensuring an adequate supply of mice (anticipated 1200-2400 per year) to meet investigator demands.
  • Potentially acquiring and adding new strains of interest to the research community.
  • Implementing cryopreservation procedures for embryos of actively produced strains.
  • Distributing models to qualified NIH-funded and non-NIH funded investigators.
  • Characterizing clinical and neurobehavioral phenotypes of the mouse models.
  • Publicizing the availability of models and associated data via a user-friendly website.
  • Convening a quarterly external Scientific Advisory Board and organizing monthly conference calls.
  • Adhering to Public Health Service Policy on Humane Care and Use of Laboratory Animals, NIH policies on reproducibility, rigor, transparency, and data sharing.

Contract Details

  • Contract Type: Cost-Reimbursement level of effort.
  • Period of Performance: A one-year base period (anticipated September 25, 2026 - September 24, 2027) with four one-year option periods, totaling up to five years (through September 24, 2031).
  • NAICS Code: 541714 (Research and Development in Biotechnology), with a small business size standard of 1,000 employees.
  • Estimated Cost: To be determined (TBD) for the base period.

Submission & Evaluation

  • Proposal Submission Deadline: May 28, 2026, at 4:30 PM Eastern Time.
  • Questions Deadline: May 1, 2026.
  • Submission Method: Electronically via the eCPS website (https://ecps.nih.gov).
  • Evaluation Factors: Proposals will be evaluated based on Technical merit, Cost/Price, and Past Performance.
  • Eligibility: This is an unrestricted acquisition, open to all qualified offerors. Offerors must be registered in the System for Award Management (SAM.gov).

Additional Notes

This solicitation incorporates numerous FAR and HHSAR clauses. Offerors are responsible for monitoring SAM.gov for any amendments. The Government reserves the right to make a single award, multiple awards, or no award.

People

Points of Contact

Files

Files

Download
Download

Versions

Version 5
Solicitation
Posted: Apr 24, 2026
View
Version 4
Solicitation
Posted: Apr 16, 2026
View
Version 3Viewing
Solicitation
Posted: Apr 14, 2026
Version 2
Pre-Solicitation
Posted: Mar 27, 2026
View
Version 1
Sources Sought
Posted: Mar 9, 2026
View